当前位置: X-MOL 学术Chem. Biol. Interact. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antiangiogenic and antitumoral activity of LQFM126 prototype against B16F10 melanoma cells.
Chemico-Biological Interactions ( IF 5.1 ) Pub Date : 2020-05-11 , DOI: 10.1016/j.cbi.2020.109127
Artur Christian Garcia da Silva 1 , Bruna Dos Santos Rodrigues 1 , Wanessa Machado Andrade 1 , Thaís Rosa Marques Dos Santos 1 , Flávio Silva de Carvalho 2 , Germán Sanz 3 , Boniek G Vaz 3 , Luciano M Lião 2 , Ricardo Menegatti 4 , Marize Campos Valadares 1
Affiliation  

Inhibition of mouse double minute 2 homolog (MDM2)-p53 interaction and reactivation of p53 signaling have been explored as effective anticancer therapeutic strategy. The potent and specific antitumor activity shown by Nutlins, first class of MDM2-p53 inhibitors discovered, has made these compounds potential antitumor candidates. To this end, we synthesized Nutlin-1 and Nutlin-2 analogs through molecular simplification and selected the compound with the most efficient antitumoral activity. Cytotoxicity of Nutlin-2 analog LQFM126 on B16F10 melanoma cells induced intense cytoplasmic vacuolization, reduction of cell size, chromatin condensation, cytoplasmic degeneration and nuclear fragmentation. LQFM126 antiproliferative effects mediated cell cycle retention in G0/G1 phase and increased the levels of cell cycle regulatory proteins p21 and p27. This Nutlin analog increased mitochondrial membrane potential, activated caspase-8, -9 and -3/7 and reduced VEGF levels in B16F10 cells. Therefore, LQFM126 promoted alterations suggestive of apoptosis, G0/G1 cell cycle arrest and suppression of angiogenesis through modulation of VEGF expression in B16F10 cells. Additionally, LQFM126 was classified as UN GHS category 4 (LD50 > 300-2000 mg/kg), suggesting it has low acute systemic toxicity. LQFM126 can be a promising prototype for anticancer therapy.

中文翻译:

LQFM126原型针对B16F10黑色素瘤细胞的抗血管生成和抗肿瘤活性。

已经研究了抑制小鼠双分钟2同源物(MDM2)-p53相互作用和p53信号传导的重新激活作为有效的抗癌治疗策略。Nutlins是发现的第一类MDM2-p53抑制剂,显示出有效的抗肿瘤活性,这些化合物已成为潜在的抗肿瘤候选药物。为此,我们通过分子简化合成了Nutlin-1和Nutlin-2类似物,并选择了具有最有效抗肿瘤活性的化合物。Nutlin-2类似物LQFM126对B16F10黑色素瘤细胞的细胞毒性诱导了强烈的细胞质空泡,细胞大小减少,染色质浓缩,细胞质变性和核碎裂。LQFM126的抗增殖作用介导了细胞周期停留在G0 / G1期,并增加了细胞周期调节蛋白p21和p27的水平。这种Nutlin类似物可增加线粒体膜电位,激活caspase-8,-9和-3/7并降低B16F10细胞中的VEGF水平。因此,LQFM126通过调节B16F10细胞中VEGF的表达来促进细胞凋亡,G0 / G1细胞周期阻滞和血管生成抑制的改变。此外,LQFM126被列为联合国GHS类别4(LD50> 300-2000 mg / kg),表明其急性全身毒性较低。LQFM126可能是抗癌治疗的有希望的原型。LQFM126被列为联合国GHS类别4(LD50> 300-2000 mg / kg),表明它的急性全身毒性较低。LQFM126可能是抗癌治疗的有希望的原型。LQFM126被列为联合国GHS类别4(LD50> 300-2000 mg / kg),表明它的急性全身毒性较低。LQFM126可能是抗癌治疗的有希望的原型。
更新日期:2020-05-11
down
wechat
bug